Dostarlimab, Zynteglo & COVID-19 Combo Drugs In The Spotlight At EMA

22 Feb 2021

The sponsors of seven new drugs are set to find out this week whether the European Medicines Agency’s human medicines committee, the CHMP, will recommend pan-EU approval for their products. CHMP action is also expected regarding two potential combination therapies for COVID-19.

Scientific opinions are due on the use of two combination treatments for COVID-19 in the EU • Source: Shutterstock

Dostarlimab, Zynteglo & COVID-19 Combo Drugs In The Spotlight At EMA

More from Europe

More from Geography